CHEMICAL SYNTHESIS, SITE-SPECIFIC LABELLING AND BIOLOGICAL EVALUATION/PK OF HEPARAN SULPHATE OLIGOSACCHARIDES

Gavin J. Miller 1 Steen U. Hansen 1 Marek Baráth 1 Karl Broberg 1 Egle Avizientye 2 Claire L. Cole 2 Graham Rushton 2 Gordon C. Jayson 2 John M. Gardiner 1
1Manchester Institute of Biotechnology and School of Chemistry, The University of Manchester, Manchester
2School of Cancer and Enabling Sciences, The University of Manchester, Manchester

Heparin and heparan sulfate (H/HS) are highly charged, ubiquitous, naturally occurring glycosaminoglycans (GAGs) which are involved in regulating a wide range of biologically important cellular signalling events that control a variety of biological functions.1 Despite advances in separation techniques,2 the complex heterogeneity of natural H/HS oligosaccharides means that defining the roles of specific sequences is best addressed by precise chemical synthesis of a diversity of structurally defined sequences.

We describe here our syntheses of a range of oligosaccharides (up to dodecasaccharide length) with key, pre-installed diversity to investigate alternating sulfation patterns, underpinned by our recently reported new routes to heparin-related disaccharide and oligosaccharide modules.3 The synthesis provides a modular approach to these different targets, which has enabled biological evaluation (in vitro and in vivo) of a range of synthetic oligosaccharides for FGF binding, cell proliferation and migration experiments. The structure-biological effect information regarding length and specific sulfation effects, we have thus been able to obtain from a matrix of synthetic compounds will be presented here. We have also developed syntheses to provide versatile new end-labellable oligosaccharides, applicable to a range of conjugation and labelling strategies. This includes using a tetrasaccharide-module approach to rapidly access an end-modified bioactive dodecasaccharide then employed for specific 3H-labelling enabling us to conduct in vivo monitoring and PK studies.


 

1. (a) Casu, B.; Naggi, A.; Torri, G. Matrix Biology 2010, 29, 442-452. (b) Bishop, J.; Schuksz, M; Esko, J. D. Nature 2007, 446, 1030–1037.

2. Laremore, T. N.; Ly, M.; Solakyildirim, K.; Zagorevski, D. V.; Lindhardt, R. J. Anal. Biochem. 2010, 401, 236-241.

3. (a) Hansen, S. U.; Miller, G. M.; Jayson, G. C.; Gardiner, J. M. J. Org. Chem. 2012, 77, 7823–7843. (b) Hansen, S. U.; Miller, G. J.; Jayson, G. C.; Gardiner, J. M. Organic Letters, 2013, 15, 88–91.

 








 




Powered by Eventact EMS